Global Oncolytic Virus Manufacturing and Development Services Market
授權報價
| Single User License | $3,480 USD |
| Multi User License | $5,220 USD |
| Corporate Users License | $6,960 USD |
完整報告名稱與涵蓋範圍
Global Oncolytic Virus Manufacturing and Development Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032
報告摘要
According to our (Global Info Research) latest study, the global Oncolytic Virus Manufacturing and Development Services market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Oncolytic Virus Manufacturing and Development Services encompass the specialized processes involved in creating and optimizing viruses that selectively infect and destroy cancer cells. These services include the development of viral vectors, process optimization, large-scale production, purification, and quality control of oncolytic viruses. Additionally, they involve regulatory support, preclinical testing, and clinical trial manufacturing. The goal is to ensure that these viruses are produced safely and effectively for use in therapeutic applications, including cancer immunotherapy and combination treatments with other modalities.
This report is a detailed and comprehensive analysis for global Oncolytic Virus Manufacturing and Development Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oncolytic Virus Manufacturing and Development Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global Oncolytic Virus Manufacturing and Development Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Oncolytic Virus Manufacturing and Development Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Oncolytic Virus Manufacturing and Development Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncolytic Virus Manufacturing and Development Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncolytic Virus Manufacturing and Development Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recipharm (Vibalogics), IDT Biologika, FUJIFILM Diosynth Biotechnologies, Exothera, Lonza, Creative Biolabs, Takara Bio, Libentech, ABL, Nabios, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oncolytic Virus Manufacturing and Development Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oncolytic Herpes Simplex Virus
Oncolytic Adenovirus
Oncolytic Vaccinia Virus
Others
Market segment by Application
R&D
Biopharmaceutical Manufacturers
Others
Market segment by players, this report covers
Recipharm (Vibalogics)
IDT Biologika
FUJIFILM Diosynth Biotechnologies
Exothera
Lonza
Creative Biolabs
Takara Bio
Libentech
ABL
Nabios
Halix
Obio Technology
Porton Advanced
WuXi ATU
Genevoyager
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncolytic Virus Manufacturing and Development Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncolytic Virus Manufacturing and Development Services, with revenue, gross margin, and global market share of Oncolytic Virus Manufacturing and Development Services from 2021 to 2026.
Chapter 3, the Oncolytic Virus Manufacturing and Development Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Oncolytic Virus Manufacturing and Development Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncolytic Virus Manufacturing and Development Services.
Chapter 13, to describe Oncolytic Virus Manufacturing and Development Services research findings and conclusion.
目錄 Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncolytic Virus Manufacturing and Development Services by Type
1.3.1 Overview: Global Oncolytic Virus Manufacturing and Development Services Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Type in 2025
1.3.3 Oncolytic Herpes Simplex Virus
1.3.4 Oncolytic Adenovirus
1.3.5 Oncolytic Vaccinia Virus
1.3.6 Others
1.4 Global Oncolytic Virus Manufacturing and Development Services Market by Application
1.4.1 Overview: Global Oncolytic Virus Manufacturing and Development Services Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 R&D
1.4.3 Biopharmaceutical Manufacturers
1.4.4 Others
1.5 Global Oncolytic Virus Manufacturing and Development Services Market Size & Forecast
1.6 Global Oncolytic Virus Manufacturing and Development Services Market Size and Forecast by Region
1.6.1 Global Oncolytic Virus Manufacturing and Development Services Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Oncolytic Virus Manufacturing and Development Services Market Size by Region, (2021-2032)
1.6.3 North America Oncolytic Virus Manufacturing and Development Services Market Size and Prospect (2021-2032)
1.6.4 Europe Oncolytic Virus Manufacturing and Development Services Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size and Prospect (2021-2032)
1.6.6 South America Oncolytic Virus Manufacturing and Development Services Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size and Prospect (2021-2032)
2 Company Profiles
2.1 Recipharm (Vibalogics)
2.1.1 Recipharm (Vibalogics) Details
2.1.2 Recipharm (Vibalogics) Major Business
2.1.3 Recipharm (Vibalogics) Oncolytic Virus Manufacturing and Development Services Product and Solutions
2.1.4 Recipharm (Vibalogics) Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Recipharm (Vibalogics) Recent Developments and Future Plans
2.2 IDT Biologika
2.2.1 IDT Biologika Details
2.2.2 IDT Biologika Major Business
2.2.3 IDT Biologika Oncolytic Virus Manufacturing and Development Services Product and Solutions
2.2.4 IDT Biologika Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 IDT Biologika Recent Developments and Future Plans
2.3 FUJIFILM Diosynth Biotechnologies
2.3.1 FUJIFILM Diosynth Biotechnologies Details
2.3.2 FUJIFILM Diosynth Biotechnologies Major Business
2.3.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing and Development Services Product and Solutions
2.3.4 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.4 Exothera
2.4.1 Exothera Details
2.4.2 Exothera Major Business
2.4.3 Exothera Oncolytic Virus Manufacturing and Development Services Product and Solutions
2.4.4 Exothera Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Exothera Recent Developments and Future Plans
2.5 Lonza
2.5.1 Lonza Details
2.5.2 Lonza Major Business
2.5.3 Lonza Oncolytic Virus Manufacturing and Development Services Product and Solutions
2.5.4 Lonza Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Lonza Recent Developments and Future Plans
2.6 Creative Biolabs
2.6.1 Creative Biolabs Details
2.6.2 Creative Biolabs Major Business
2.6.3 Creative Biolabs Oncolytic Virus Manufacturing and Development Services Product and Solutions
2.6.4 Creative Biolabs Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Creative Biolabs Recent Developments and Future Plans
2.7 Takara Bio
2.7.1 Takara Bio Details
2.7.2 Takara Bio Major Business
2.7.3 Takara Bio Oncolytic Virus Manufacturing and Development Services Product and Solutions
2.7.4 Takara Bio Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Takara Bio Recent Developments and Future Plans
2.8 Libentech
2.8.1 Libentech Details
2.8.2 Libentech Major Business
2.8.3 Libentech Oncolytic Virus Manufacturing and Development Services Product and Solutions
2.8.4 Libentech Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Libentech Recent Developments and Future Plans
2.9 ABL
2.9.1 ABL Details
2.9.2 ABL Major Business
2.9.3 ABL Oncolytic Virus Manufacturing and Development Services Product and Solutions
2.9.4 ABL Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 ABL Recent Developments and Future Plans
2.10 Nabios
2.10.1 Nabios Details
2.10.2 Nabios Major Business
2.10.3 Nabios Oncolytic Virus Manufacturing and Development Services Product and Solutions
2.10.4 Nabios Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Nabios Recent Developments and Future Plans
2.11 Halix
2.11.1 Halix Details
2.11.2 Halix Major Business
2.11.3 Halix Oncolytic Virus Manufacturing and Development Services Product and Solutions
2.11.4 Halix Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Halix Recent Developments and Future Plans
2.12 Obio Technology
2.12.1 Obio Technology Details
2.12.2 Obio Technology Major Business
2.12.3 Obio Technology Oncolytic Virus Manufacturing and Development Services Product and Solutions
2.12.4 Obio Technology Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Obio Technology Recent Developments and Future Plans
2.13 Porton Advanced
2.13.1 Porton Advanced Details
2.13.2 Porton Advanced Major Business
2.13.3 Porton Advanced Oncolytic Virus Manufacturing and Development Services Product and Solutions
2.13.4 Porton Advanced Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Porton Advanced Recent Developments and Future Plans
2.14 WuXi ATU
2.14.1 WuXi ATU Details
2.14.2 WuXi ATU Major Business
2.14.3 WuXi ATU Oncolytic Virus Manufacturing and Development Services Product and Solutions
2.14.4 WuXi ATU Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 WuXi ATU Recent Developments and Future Plans
2.15 Genevoyager
2.15.1 Genevoyager Details
2.15.2 Genevoyager Major Business
2.15.3 Genevoyager Oncolytic Virus Manufacturing and Development Services Product and Solutions
2.15.4 Genevoyager Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Genevoyager Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oncolytic Virus Manufacturing and Development Services Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Oncolytic Virus Manufacturing and Development Services by Company Revenue
3.2.2 Top 3 Oncolytic Virus Manufacturing and Development Services Players Market Share in 2025
3.2.3 Top 6 Oncolytic Virus Manufacturing and Development Services Players Market Share in 2025
3.3 Oncolytic Virus Manufacturing and Development Services Market: Overall Company Footprint Analysis
3.3.1 Oncolytic Virus Manufacturing and Development Services Market: Region Footprint
3.3.2 Oncolytic Virus Manufacturing and Development Services Market: Company Product Type Footprint
3.3.3 Oncolytic Virus Manufacturing and Development Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Oncolytic Virus Manufacturing and Development Services Consumption Value and Market Share by Type (2021-2026)
4.2 Global Oncolytic Virus Manufacturing and Development Services Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
5.1 Global Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Application (2021-2026)
5.2 Global Oncolytic Virus Manufacturing and Development Services Market Forecast by Application (2027-2032)
6 North America
6.1 North America Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2021-2032)
6.2 North America Oncolytic Virus Manufacturing and Development Services Market Size by Application (2021-2032)
6.3 North America Oncolytic Virus Manufacturing and Development Services Market Size by Country
6.3.1 North America Oncolytic Virus Manufacturing and Development Services Consumption Value by Country (2021-2032)
6.3.2 United States Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
6.3.3 Canada Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
6.3.4 Mexico Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
7 Europe
7.1 Europe Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2021-2032)
7.2 Europe Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2021-2032)
7.3 Europe Oncolytic Virus Manufacturing and Development Services Market Size by Country
7.3.1 Europe Oncolytic Virus Manufacturing and Development Services Consumption Value by Country (2021-2032)
7.3.2 Germany Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
7.3.3 France Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
7.3.5 Russia Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
7.3.6 Italy Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size by Region
8.3.1 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Consumption Value by Region (2021-2032)
8.3.2 China Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
8.3.3 Japan Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
8.3.4 South Korea Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
8.3.5 India Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
8.3.7 Australia Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
9 South America
9.1 South America Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2021-2032)
9.2 South America Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2021-2032)
9.3 South America Oncolytic Virus Manufacturing and Development Services Market Size by Country
9.3.1 South America Oncolytic Virus Manufacturing and Development Services Consumption Value by Country (2021-2032)
9.3.2 Brazil Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
9.3.3 Argentina Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size by Country
10.3.1 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Consumption Value by Country (2021-2032)
10.3.2 Turkey Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
10.3.4 UAE Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
11 Market Dynamics
11.1 Oncolytic Virus Manufacturing and Development Services Market Drivers
11.2 Oncolytic Virus Manufacturing and Development Services Market Restraints
11.3 Oncolytic Virus Manufacturing and Development Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Oncolytic Virus Manufacturing and Development Services Industry Chain
12.2 Oncolytic Virus Manufacturing and Development Services Upstream Analysis
12.3 Oncolytic Virus Manufacturing and Development Services Midstream Analysis
12.4 Oncolytic Virus Manufacturing and Development Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Global Oncolytic Virus Manufacturing and Development Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Oncolytic Virus Manufacturing and Development Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Oncolytic Virus Manufacturing and Development Services Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Oncolytic Virus Manufacturing and Development Services Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Recipharm (Vibalogics) Company Information, Head Office, and Major Competitors
Table 6. Recipharm (Vibalogics) Major Business
Table 7. Recipharm (Vibalogics) Oncolytic Virus Manufacturing and Development Services Product and Solutions
Table 8. Recipharm (Vibalogics) Oncolytic Virus Manufacturing and Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Recipharm (Vibalogics) Recent Developments and Future Plans
Table 10. IDT Biologika Company Information, Head Office, and Major Competitors
Table 11. IDT Biologika Major Business
Table 12. IDT Biologika Oncolytic Virus Manufacturing and Development Services Product and Solutions
Table 13. IDT Biologika Oncolytic Virus Manufacturing and Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. IDT Biologika Recent Developments and Future Plans
Table 15. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 16. FUJIFILM Diosynth Biotechnologies Major Business
Table 17. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing and Development Services Product and Solutions
Table 18. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing and Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Exothera Company Information, Head Office, and Major Competitors
Table 20. Exothera Major Business
Table 21. Exothera Oncolytic Virus Manufacturing and Development Services Product and Solutions
Table 22. Exothera Oncolytic Virus Manufacturing and Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Exothera Recent Developments and Future Plans
Table 24. Lonza Company Information, Head Office, and Major Competitors
Table 25. Lonza Major Business
Table 26. Lonza Oncolytic Virus Manufacturing and Development Services Product and Solutions
Table 27. Lonza Oncolytic Virus Manufacturing and Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Lonza Recent Developments and Future Plans
Table 29. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 30. Creative Biolabs Major Business
Table 31. Creative Biolabs Oncolytic Virus Manufacturing and Development Services Product and Solutions
Table 32. Creative Biolabs Oncolytic Virus Manufacturing and Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Creative Biolabs Recent Developments and Future Plans
Table 34. Takara Bio Company Information, Head Office, and Major Competitors
Table 35. Takara Bio Major Business
Table 36. Takara Bio Oncolytic Virus Manufacturing and Development Services Product and Solutions
Table 37. Takara Bio Oncolytic Virus Manufacturing and Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Takara Bio Recent Developments and Future Plans
Table 39. Libentech Company Information, Head Office, and Major Competitors
Table 40. Libentech Major Business
Table 41. Libentech Oncolytic Virus Manufacturing and Development Services Product and Solutions
Table 42. Libentech Oncolytic Virus Manufacturing and Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Libentech Recent Developments and Future Plans
Table 44. ABL Company Information, Head Office, and Major Competitors
Table 45. ABL Major Business
Table 46. ABL Oncolytic Virus Manufacturing and Development Services Product and Solutions
Table 47. ABL Oncolytic Virus Manufacturing and Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. ABL Recent Developments and Future Plans
Table 49. Nabios Company Information, Head Office, and Major Competitors
Table 50. Nabios Major Business
Table 51. Nabios Oncolytic Virus Manufacturing and Development Services Product and Solutions
Table 52. Nabios Oncolytic Virus Manufacturing and Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Nabios Recent Developments and Future Plans
Table 54. Halix Company Information, Head Office, and Major Competitors
Table 55. Halix Major Business
Table 56. Halix Oncolytic Virus Manufacturing and Development Services Product and Solutions
Table 57. Halix Oncolytic Virus Manufacturing and Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Halix Recent Developments and Future Plans
Table 59. Obio Technology Company Information, Head Office, and Major Competitors
Table 60. Obio Technology Major Business
Table 61. Obio Technology Oncolytic Virus Manufacturing and Development Services Product and Solutions
Table 62. Obio Technology Oncolytic Virus Manufacturing and Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. Obio Technology Recent Developments and Future Plans
Table 64. Porton Advanced Company Information, Head Office, and Major Competitors
Table 65. Porton Advanced Major Business
Table 66. Porton Advanced Oncolytic Virus Manufacturing and Development Services Product and Solutions
Table 67. Porton Advanced Oncolytic Virus Manufacturing and Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Porton Advanced Recent Developments and Future Plans
Table 69. WuXi ATU Company Information, Head Office, and Major Competitors
Table 70. WuXi ATU Major Business
Table 71. WuXi ATU Oncolytic Virus Manufacturing and Development Services Product and Solutions
Table 72. WuXi ATU Oncolytic Virus Manufacturing and Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. WuXi ATU Recent Developments and Future Plans
Table 74. Genevoyager Company Information, Head Office, and Major Competitors
Table 75. Genevoyager Major Business
Table 76. Genevoyager Oncolytic Virus Manufacturing and Development Services Product and Solutions
Table 77. Genevoyager Oncolytic Virus Manufacturing and Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Genevoyager Recent Developments and Future Plans
Table 79. Global Oncolytic Virus Manufacturing and Development Services Revenue (USD Million) by Players (2021-2026)
Table 80. Global Oncolytic Virus Manufacturing and Development Services Revenue Share by Players (2021-2026)
Table 81. Breakdown of Oncolytic Virus Manufacturing and Development Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 82. Market Position of Players in Oncolytic Virus Manufacturing and Development Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 83. Head Office of Key Oncolytic Virus Manufacturing and Development Services Players
Table 84. Oncolytic Virus Manufacturing and Development Services Market: Company Product Type Footprint
Table 85. Oncolytic Virus Manufacturing and Development Services Market: Company Product Application Footprint
Table 86. Oncolytic Virus Manufacturing and Development Services New Market Entrants and Barriers to Market Entry
Table 87. Oncolytic Virus Manufacturing and Development Services Mergers, Acquisition, Agreements, and Collaborations
Table 88. Global Oncolytic Virus Manufacturing and Development Services Consumption Value (USD Million) by Type (2021-2026)
Table 89. Global Oncolytic Virus Manufacturing and Development Services Consumption Value Share by Type (2021-2026)
Table 90. Global Oncolytic Virus Manufacturing and Development Services Consumption Value Forecast by Type (2027-2032)
Table 91. Global Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2021-2026)
Table 92. Global Oncolytic Virus Manufacturing and Development Services Consumption Value Forecast by Application (2027-2032)
Table 93. North America Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2021-2026) & (USD Million)
Table 94. North America Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2027-2032) & (USD Million)
Table 95. North America Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2021-2026) & (USD Million)
Table 96. North America Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2027-2032) & (USD Million)
Table 97. North America Oncolytic Virus Manufacturing and Development Services Consumption Value by Country (2021-2026) & (USD Million)
Table 98. North America Oncolytic Virus Manufacturing and Development Services Consumption Value by Country (2027-2032) & (USD Million)
Table 99. Europe Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2021-2026) & (USD Million)
Table 100. Europe Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2027-2032) & (USD Million)
Table 101. Europe Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2021-2026) & (USD Million)
Table 102. Europe Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2027-2032) & (USD Million)
Table 103. Europe Oncolytic Virus Manufacturing and Development Services Consumption Value by Country (2021-2026) & (USD Million)
Table 104. Europe Oncolytic Virus Manufacturing and Development Services Consumption Value by Country (2027-2032) & (USD Million)
Table 105. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2021-2026) & (USD Million)
Table 106. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2027-2032) & (USD Million)
Table 107. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2021-2026) & (USD Million)
Table 108. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2027-2032) & (USD Million)
Table 109. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Consumption Value by Region (2021-2026) & (USD Million)
Table 110. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Consumption Value by Region (2027-2032) & (USD Million)
Table 111. South America Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2021-2026) & (USD Million)
Table 112. South America Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2027-2032) & (USD Million)
Table 113. South America Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2021-2026) & (USD Million)
Table 114. South America Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2027-2032) & (USD Million)
Table 115. South America Oncolytic Virus Manufacturing and Development Services Consumption Value by Country (2021-2026) & (USD Million)
Table 116. South America Oncolytic Virus Manufacturing and Development Services Consumption Value by Country (2027-2032) & (USD Million)
Table 117. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2021-2026) & (USD Million)
Table 118. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2027-2032) & (USD Million)
Table 119. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2021-2026) & (USD Million)
Table 120. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2027-2032) & (USD Million)
Table 121. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Consumption Value by Country (2021-2026) & (USD Million)
Table 122. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Consumption Value by Country (2027-2032) & (USD Million)
Table 123. Global Key Players of Oncolytic Virus Manufacturing and Development Services Upstream (Raw Materials)
Table 124. Global Oncolytic Virus Manufacturing and Development Services Typical Customers
List of Figures
Figure 1. Oncolytic Virus Manufacturing and Development Services Picture
Figure 2. Global Oncolytic Virus Manufacturing and Development Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Type in 2025
Figure 4. Oncolytic Herpes Simplex Virus
Figure 5. Oncolytic Adenovirus
Figure 6. Oncolytic Vaccinia Virus
Figure 7. Others
Figure 8. Global Oncolytic Virus Manufacturing and Development Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 9. Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Application in 2025
Figure 10. R&D Picture
Figure 11. Biopharmaceutical Manufacturers Picture
Figure 12. Others Picture
Figure 13. Global Oncolytic Virus Manufacturing and Development Services Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 14. Global Oncolytic Virus Manufacturing and Development Services Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 15. Global Market Oncolytic Virus Manufacturing and Development Services Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 16. Global Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Region (2021-2032)
Figure 17. Global Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Region in 2025
Figure 18. North America Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South America Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 22. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global Oncolytic Virus Manufacturing and Development Services Revenue Share by Players in 2025
Figure 25. Oncolytic Virus Manufacturing and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 26. Market Share of Oncolytic Virus Manufacturing and Development Services by Player Revenue in 2025
Figure 27. Top 3 Oncolytic Virus Manufacturing and Development Services Players Market Share in 2025
Figure 28. Top 6 Oncolytic Virus Manufacturing and Development Services Players Market Share in 2025
Figure 29. Global Oncolytic Virus Manufacturing and Development Services Consumption Value Share by Type (2021-2026)
Figure 30. Global Oncolytic Virus Manufacturing and Development Services Market Share Forecast by Type (2027-2032)
Figure 31. Global Oncolytic Virus Manufacturing and Development Services Consumption Value Share by Application (2021-2026)
Figure 32. Global Oncolytic Virus Manufacturing and Development Services Market Share Forecast by Application (2027-2032)
Figure 33. North America Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Type (2021-2032)
Figure 34. North America Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Application (2021-2032)
Figure 35. North America Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Country (2021-2032)
Figure 36. United States Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 37. Canada Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 38. Mexico Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 39. Europe Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Type (2021-2032)
Figure 40. Europe Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Application (2021-2032)
Figure 41. Europe Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Country (2021-2032)
Figure 42. Germany Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 43. France Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 44. United Kingdom Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 45. Russia Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 46. Italy Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 47. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Type (2021-2032)
Figure 48. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Application (2021-2032)
Figure 49. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Region (2021-2032)
Figure 50. China Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 51. Japan Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 52. South Korea Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 53. India Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 54. Southeast Asia Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 55. Australia Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 56. South America Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Type (2021-2032)
Figure 57. South America Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Application (2021-2032)
Figure 58. South America Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Country (2021-2032)
Figure 59. Brazil Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 60. Argentina Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 61. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Type (2021-2032)
Figure 62. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Application (2021-2032)
Figure 63. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Country (2021-2032)
Figure 64. Turkey Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 65. Saudi Arabia Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 66. UAE Oncolytic Virus Manufacturing and Development Services Consumption Value (2021-2032) & (USD Million)
Figure 67. Oncolytic Virus Manufacturing and Development Services Market Drivers
Figure 68. Oncolytic Virus Manufacturing and Development Services Market Restraints
Figure 69. Oncolytic Virus Manufacturing and Development Services Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Oncolytic Virus Manufacturing and Development Services Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Global Info Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們